Loading...
Market
What will be Qantev's primary use of Series B funding by the end of 2025?
2
Resolution / Starting Odds
Research and Development • 25%
International Expansion • 25%
Hiring AI Talent • 25%
Marketing and Sales • 25%
Official announcements from Qantev or financial reports
Story
Qantev Raises €30M to Expand AI Claims Platform, Challenging LLMs in Health Insurance
Oct 10, 2024, 07:13 AM
Paris-based health insurtech startup Qantev has raised €30 million in a Series B funding round led by Blossom Capital, with participation from Elaia Partners, to expand its AI-driven claims management platform for health and life insurance providers. The company aims to address the increasing volume of claims due to chronic diseases and aging populations by deploying tailored small AI models that enhance efficiency and reduce costs. By challenging the large language model (LLM) craze with its specialized AI solutions, Qantev positions itself as a potential 'operating system' for health insurance. The new funding will support research and development, international expansion, and the hiring of key AI and engineering talent.
View original story
Similar markets
Product development • 25%
Market expansion • 25%
Hiring • 25%
Other • 25%
Product development • 25%
Market expansion • 25%
Hiring talent • 25%
Regulatory compliance • 25%
Expansion of 'Colossus' cluster • 25%
Acquisition of GPUs • 25%
Research and Development • 25%
Other operational expenses • 25%
Product development • 25%
Marketing and sales • 25%
Hiring and team expansion • 25%
Other • 25%
Liquidity for employees • 25%
Mergers and acquisitions • 25%
International expansion • 25%
Other purposes • 25%
Less than $10 million • 25%
$10 million to $20 million • 25%
$20 million to $30 million • 25%
More than $30 million • 25%
Product development • 25%
Marketing and sales • 25%
Hiring new employees • 25%
Other • 25%
Research and Development • 25%
Marketing and Sales • 25%
Debt Repayment • 25%
Other • 25%
Product Development • 25%
Market Expansion • 25%
Acquisitions • 25%
Operational Scaling • 25%
Less than €10 million • 25%
€10 million to €20 million • 25%
€20 million to €30 million • 25%
More than €30 million • 25%
Technology development • 25%
Market expansion • 25%
Debt repayment • 25%
Other purposes • 25%
AI infrastructure expansion • 25%
Research and development • 25%
Marketing and partnerships • 25%
Other • 25%